France€436.95+2.93%
Click any ratio for an explanation.
Revenue grew a steady +8.1% a year over the last 4 fiscal years. Profit per share grew slower (+2.9% a year), so costs are eating part of the extra revenue. Analysts expect further profit growth next year: the forward multiple is +29.2% below the trailing one.
| Ratio | Value | Weak → Strong | Score | Wt |
|---|---|---|---|---|
| +2.9% | -5% → +20% | 31 | 40% | |
| +8.1% | -2% → +15% | 59 | 35% | |
| +29.2% | -10% → +30% | 98 | 25% |
The share is up over every window (+13.6% in 3 months, +14.2% in 6, +18.6% in 12), a consistent uptrend. Recent months are weaker than the longer window, so momentum is fading.
| Ratio | Value | Weak → Strong | Score | Wt |
|---|---|---|---|---|
| +13.6% | -20% → +20% | 84 | 35% | |
| +14.2% | -25% → +30% | 71 | 30% | |
| +18.6% | -30% → +45% | 65 | 35% |
Net debt is only 1.22x EBITDA, comfortably repayable out of ordinary earnings. Debt equals 49% of equity, so the equity cushion is thick.
| Ratio | Value | Weak → Strong | Score | Wt |
|---|---|---|---|---|
| 1.2x | 3.5x → -1.0x | 51 | 30% | |
| 49% | 200% → 10% | 79 | 20% | |
| 9.5% | 0% → 15% | 63 | 15% | |
| 1.44 | 0.8x → 2.0x | 54 | 10% | |
| 6/9 | 3/9 → 8/9 | 60 | 10% | |
| 7.1 | 1.8 → 5.0 | 100 | 10% | |
| 24.2x | 2x → 20x | 100 | 5% |
Return on equity of 19.4% is respectable but not exceptional. Roughly 14% of revenue converts into net profit, an average conversion. ROIC of 17.3% confirms the returns are not just an effect of leverage.
| Ratio | Value | Weak → Strong | Score | Wt |
|---|---|---|---|---|
| 19.4% | 5% → 35% | 48 | 30% | |
| 21.3% | 3% → 30% | 68 | 25% | |
| 13.9% | 2% → 25% | 52 | 20% | |
| 17.3% | 4% → 20% | 83 | 15% | |
| 74.3% | 15% → 60% | 100 | 10% |
At 37.1x trailing earnings investors already pay up for future growth. The forward P/E of 28.7 is lower, so expected profit growth makes it look cheaper looking ahead. EV/EBITDA of 23.7 shows the premium also holds once debt is counted. Based on 75% of the inputs — the rest is not published for this instrument.
| Ratio | Value | Weak → Strong | Score | Wt |
|---|---|---|---|---|
| 37.1x | 40x → 8x | 9 | 30% | |
| 28.7x | 32x → 7x | 13 | 20% | |
| 23.7x | 22x → 6x | 0 | 15% | |
| 1.65% | 0% → 6% | 28 | 10% | |
| n/a | 1.6x → 0.7x | — | 25% |
Annualised volatility of 20.4% is normal for a single share. The worst fall in the past year was -12.1%, a shallow setback. A beta of 0.86 means it broadly follows the market.
| Ratio | Value | Weak → Strong | Score | Wt |
|---|---|---|---|---|
| 20.4% | 55% → 15% | 87 | 40% | |
| -12.1% | -40% → -8% | 87 | 35% | |
| 0.86 | 1.8 → 0.7 | 85 | 25% |
Source: Yahoo Finance + EODHD
Last 5 fiscal years plus the current year. Click any row for an explanation.
Recent analyst views
Loading analyst views…
Recent analyst actions
No individual broker rating actions are published for this instrument.
- Mean target
- €433.00
- Target range
- €360.00 – €500.00
- Implied upside
- -0.9%
- Consensus score
- 2.04
Quarterly results · 11 Feb 2027
Reports after market close
Dividend
Forward annual dividend 7.2 EUR; last ex-dividend 2026-04-29. Next date not yet published
Investor day
Checking public announcements…
Mergers & acquisitions
Checking public announcements…
Loading headlines…
L'Oréal S.A., through its subsidiaries, manufactures and sells cosmetic products for women and men in Europe, North America, North Asia, South Asia Pacific, the Middle East, North Africa, Sub-Saharan Africa, and Latin America. It operates through four divisions: Professional Products, Consumer Products, Luxe, and Dermatological Beauty. The company offers skincare, make-up, hair colourant, haircare, perfume, and hygiene products. It provides its products under the L'Oréal Paris, Garnier, Maybelline New York, NYX Professional Makeup, Stylenanda, Essie, Dark & Lovely, Mixa, Niely, L'Oréal Professionnel, Kérastase, Redken, Matrix, Pureology, Lancôme, Yves Saint Laurent Beauté, Armani Beauty, Kiehl's, Helena Rubinstein, Aesop, Biotherm, Valentino, Prada, Shu Uemura, IT Cosmetics, Mugler, Ralph Lauren, Urban Decay, Azzaro, Maison Margiela, Viktor&Rolf, Takami, La RochePosay, CeraVe, Vichy, SkinCeuticals, Skinbetter Science, and other brand names. The company sells its products through distribution channels, such as hair salons, local stores, e-commerce, travel retail, mass market retail, department store perfumeries, pharmacies, drug stores, medi-spas, and free-standing stores. L'Oréal S.A. was founded in 1909 and is headquartered in Clichy, France.
loreal.com